Rheumatoid arthritis in remission

Remission in Rheumatoid Arthritis

With advancing therapeutic options, achieving a state of remission has become the treatment goal in rheumatoid arthritis. Agreeing on what constitutes remission and what measures should be used to assess disease activity has remained a challenge. Multiple remission criteria have been devised and modified, all with different strengths and limitations. A consensus definition of remission will nee...

Patient-reported remission in rheumatoid arthritis.

Remission: a realistic goal in rheumatoid arthritis?

Remission in randomized clinical trials The FIN-RACo study was the first randomized controlled rheumatoid arthritis (RA) trial that used remission as the primary outcome measure [1]. In the FIN-RACo trial, remission was defined as the treatment goal and the primary outcome measure as early as 1993, years before the first biologic agent became available. Results of FIN-RACo were amazing: 42% of ...

Clinical remission in rheumatoid arthritis and psoriatic arthritis.

It is currently recognised that remission can be an achievable target for several rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients by a treat-to-target approach. For RA different remission criteria have been proposed, depending on the disease activity scores used, on the importance given to the inclusion of patients' perspective into the definition of remission, and on their app...

Comparing bone mineral density in rheumatoid arthritis and psoriatic arthritis

Background: Changes in patients’ bone mineral density (BMD) is one of the problems in patients with rheumatoid arthritis, which can be due to the use of corticosteroid drugs to reduce patients' symptoms or due to the aging process in patients. In this study, we decided to compare BMD in patients with psoriatic arthritis and rheumatoid arthritis. Methods: This study as a cross-sectional descrip...